BIIB Biogen
- Official Name: BIOGEN INC.
- Headquarters: 225 Binney Street, CAMBRIDGE, MA, 02142 US
- CEO: Christopher Viehbacher
- Website: biogen.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1R | Won by 0.199 | (2.871) - (3.070) | ||
| 2025-07-18 | 1 | Lost by 6.858 | (5.609) - 1.249 | ||
| 2025-07-25 | 2 | Lost by 5.743 | 4.549 - 10.292 | ||
| 2025-07-29 | 2R | Lost by 2.129 | (1.652) - 0.477 | ||
| 2025-08-01 | 3 | Won by 6.740 | 0.635 - (6.105) | ||
| 2025-08-07 | 1R | Won by 0.254 | (1.225) - (1.479) | ||
| 2025-08-08 | 4 | Lost by 14.390 | 1.196 - 15.586 | ||
| 2025-08-15 | 5 | Lost by 1.151 | 5.113 - 6.264 | ||
| 2025-08-21 | 2R | Lost by 0.219 | 0.103 - 0.322 | ||
| 2025-08-22 | 6 | Lost by 0.017 | 1.483 - 1.500 | ||
| 2025-08-29 | 7 | Lost by 2.894 | (5.096) - (2.202) | ||
| 2025-09-05 | 8 | Won by 8.761 TOTW | 5.971 - (2.790) | ||
| 2025-09-12 | 9 | Won by 3.263 TOTW | 3.224 - (0.039) | ||
| 2025-09-19 | 10 | Lost by 4.358 | (1.568) - 2.790 | ||
| 2025-09-26 | 11 | Lost by 2.680 | (3.463) - (0.783) | ||
| 2025-10-03 | 12 | Won by 15.386 | 13.959 - (1.427) | ||
| 2025-10-10 | 13 | Lost by 4.077 | (8.310) - (4.233) | ||
| 2025-10-17 | 14 | Lost by 2.433 | (2.474) - (0.041) | ||
| 2025-10-24 | 15 | Lost by 2.567 | 5.084 - 7.651 |
Latest News
Yahoo - 2026-10-16
A kidney transplant milestone has Wall Street excited about Biogen
JPMorgan strongly reset its price target on the company’s attractive 2027 pipeline catalysts.
Yahoo - 2026-10-16
Another Biotech IPO Pops on Rough Day for Broader Market
It's another risk-off day for the broader market, with tech taking another tumble, thanks to a continued slide for semiconductor stocks.
Yahoo - 2026-10-16
Biogen-backed Estuary nabs $93M for kidney disease gene therapy
The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an inherited kidney disorde...
SeekingAlpha - 2026-10-16
Biogen: The Bull Case Is Extending Beyond Alzheimer's (Rating Upgrade)
Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimerâs revenue growth, and key risk/reward driversâread now. Cli...
SeekingAlpha - 2026-10-15
Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform
Yahoo - 2026-10-13
Phanes Therapeutics to participate in Longwood Healthcare Leaders Boston CEO, November 2-3, 2026
Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology (IO), ann...
Yahoo - 2026-10-13
Biogen’s Quarterly Earnings Preview: What You Need to Know
Biogen is set to report its Q3 results soon, with analysts expecting a sharp double-digit decline in EPS.
Show more
Yahoo - 2026-10-12
Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?
Yahoo - 2026-10-12
Biogen (BIIB) Stock Is Up, What You Need To Know
Yahoo - 2026-10-12
Biogen (BIIB) Stock May Be 49% Below Fair Value As Lupus Data Loom
Yahoo - 2026-10-12
What Biogen (BIIB)'s 52-Week Litifilimab CLE Data Means For Shareholders
Yahoo - 2026-10-12
Sector Update: Healthcare Stocks Rise Late Afternoon
Yahoo - 2026-10-12
Biogen (BIIB) Could Be 5% Undervalued After 52 Week Lupus Data
ChartMill - 2026-10-12
Discover which S&P500 stocks are making waves on Monday.
Yahoo - 2026-10-12
Biogen Upgraded to Buy at J.P. Morgan. How the Stock Could Rise 28%.
Yahoo - 2026-10-12
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
ChartMill - 2026-10-12
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Yahoo - 2026-10-12
JPMorgan gets bullish on Biogen ahead of 2027 catalysts
Yahoo - 2026-10-12
BIIB Stock: JPMorgan Sees ‘Increasingly Compelling Catalyst Path’ For Biogen, Raises Price Target To $300
Yahoo - 2026-10-12
2 Surging Stocks for Long-Term Investors and 1 We Brush Off
Benzinga - 2026-10-12
JP Morgan Upgrades Biogen to Overweight, Raises Price Target to $300
Benzinga - 2026-10-09
UBS Maintains Buy on Biogen, Raises Price Target to $270
Benzinga - 2026-10-08
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $256
SeekingAlpha - 2026-10-07
Stock Picks From Seeking Alpha's September 2026 New Analysts
Yahoo - 2026-10-06
Biogen expected to slightly beat third-quarter earnings as lupus trial data loom, Jefferies says
Yahoo - 2026-10-06
Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?
Benzinga - 2026-10-05
4 Health Care Stocks With Whale Alerts In Today’s Session
SeekingAlpha - 2026-10-04
Design Therapeutics: 'Hold' DT-216P2 Registrational FA Plans Q4 2026 And 12-Week Results Q1 2027
Yahoo - 2026-10-02
Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise?
Yahoo - 2026-10-01
1 Profitable Stock Worth Investigating and 2 We Ignore
Yahoo - 2026-10-01
HLS Therapeutics Announces Board of Directors Changes
Yahoo - 2026-09-29
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Yahoo - 2026-09-28
Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?
Yahoo - 2026-09-25
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
Benzinga - 2026-09-24
10 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-09-23
How Investors May Respond To Biogen (BIIB) Advancing At-Home LEQEMBI Pen And Kidney Disease Data
Yahoo - 2026-09-23
Biogen (BIIB) Posts New Kidney Trial Data, Is It Still 5% Undervalued?
CNBC - 2026-09-22
Novo defends diversification push as CEO eyes deals beyond obesity
Yahoo - 2026-09-21
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
CNBC - 2026-09-21
Novo shares slide as drugmaker lays out post-Wegovy growth strategy
Benzinga - 2026-09-17
Biogen Announces Publication Of Phase 3 VALIANT Adolescent Subgroup Data In CJASN Demonstrating 75% Proteinuria Reduction For EMPAVELI In Rare Kidney Diseases
SeekingAlpha - 2026-09-17
Biogen: Growth Is Back, But It Came At A Price
Yahoo - 2026-09-16
How AbbVie's Neuroscience Portfolio Has Transformed Over the Years
Yahoo - 2026-09-16
Is Biogen Stock Outperforming the S&P 500?
Yahoo - 2026-09-16
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
Yahoo - 2026-09-15
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
Yahoo - 2026-09-15
Hummingbird Bioscience Appoints Dr. James Garner as President
Yahoo - 2026-09-15
Biogen Eyes Wave of Phase III Readouts as It Expands Beyond Neuroscience
SeekingAlpha - 2026-09-14
Biogen Inc. (BIIB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Yahoo - 2026-09-12
Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology
ChartMill - 2026-09-10
Thursday's session: top gainers and losers in the S&P500 index
Benzinga - 2026-09-10
HSBC Maintains Reduce on Biogen, Raises Price Target to $175
SeekingAlpha - 2026-09-09
Biogen Inc. (BIIB) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
CNBC - 2026-09-09
Biogen CEO: We are at that inflection point where we are on a path to sustainable revenue growth
Yahoo - 2026-09-08
Register Now: Limited Seating Remains for HMG Strategy’s Sept. 10 Boston C-Level Technology Leadership Summit
Yahoo - 2026-09-08
Lilly Builds Neuroscience into a New Long-Term Growth Driver
Yahoo - 2026-09-04
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
Yahoo - 2026-09-04
Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?
Yahoo - 2026-09-04
Why Is Veeva Systems (VEEV) Winning Big In AI For Biopharma?
Benzinga - 2026-09-04
Stoke, Biogen Report Lasting Seizure Reductions In Dravet Syndrome Study
Benzinga - 2026-09-03
Piper Sandler Reiterates Overweight on Biogen, Raises Price Target to $245
Benzinga - 2026-09-03
Biogen And Eisai Win China Approval For At-Home Weekly Leqembi Alzheimer’s Treatment
Yahoo - 2026-09-03
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
Yahoo - 2026-09-02
Biogen (BIIB) Stock Could Be 48% Below Fair Value On New Dravet Data
Yahoo - 2026-09-02
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Yahoo - 2026-09-02
Biogen’s (BIIB) Immunology Bet Meets A Pricier Balance Sheet
Benzinga - 2026-09-01
Stoke Therapeutics, Biogen Present Data On Zorevunersen As Treatment For Dravet Syndrome At 16th European Epilepsy Congress
Yahoo - 2026-08-31
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
Yahoo - 2026-08-30
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks
Yahoo - 2026-08-28
Why Is Biogen (BIIB) Up 6.5% Since Last Earnings Report?
Yahoo - 2026-08-27
Veeva Systems Inc (VEEV) (Q2 2027) Earnings Call Highlights: Record CRM Quarter and AI Momentum ...
Yahoo - 2026-08-26
Veeva Systems Q2 Earnings Call Highlights
SeekingAlpha - 2026-08-26
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade)
Yahoo - 2026-08-25
Veeva's Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist Says
Yahoo - 2026-08-25
3 Reasons to Sell BIIB and 1 Stock to Buy Instead
Yahoo - 2026-08-25
Veeva Vault CRM Selected by Biogen
Benzinga - 2026-08-25
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $260
SeekingAlpha - 2026-08-24
Acadia Pharmaceuticals: Another Bite At The Alzheimer's Apple
Yahoo - 2026-08-24
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
Yahoo - 2026-08-24
LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
Benzinga - 2026-08-24
Eisai And Biogen Announce Once Weekly Lecanemab-Irmb Subcutaneous Injection Is Now Available In U.S. For Initiation Therapy For Early Alzheimer’s Disease
SeekingAlpha - 2026-08-22
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
Yahoo - 2026-08-21
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders
Yahoo - 2026-08-20
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
Yahoo - 2026-08-20
Is Wall Street Bullish or Bearish on Biogen Stock?
Yahoo - 2026-08-19
Real Parkinson’s Disease Hope from Jupiter Neurosciences
ChartMill - 2026-08-17
Biogen (NASDAQ:BIIB) Shows Strong Technical Breakout Setup With Perfect Trend Rating
Benzinga - 2026-08-13
Wolfe Research Upgrades Biogen to Outperform, Announces $300 Price Target
Yahoo - 2026-08-11
NovelMed Advances NM5072 for Multiple Ocular Disorders
Yahoo - 2026-08-07
Biogen (BIIB) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-07
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum
Yahoo - 2026-08-06
Biogen Completes Acquisition of RayThera Inc.
SeekingAlpha - 2026-08-05
Stoke: 'Buy' On Zorevunersen NDA SCN1A DS And STK-002 Advancement
Yahoo - 2026-08-05
Biogen Stock: How To Find & Own America's Greatest Opportunities
Benzinga - 2026-08-04
Mizuho Maintains Outperform on Biogen, Raises Price Target to $241
Benzinga - 2026-08-04
Incyte Appoints Suketu (Suky) Upadhyay As Executive Vice President And CFO Effective May 4, 2026
Yahoo - 2026-08-03
Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?
Benzinga - 2026-08-03
Citigroup Maintains Neutral on Biogen, Raises Price Target to $215
Yahoo - 2026-08-03
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
Yahoo - 2026-07-31
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Yahoo - 2026-07-30
IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook
Benzinga - 2026-07-30
UBS Maintains Buy on Biogen, Raises Price Target to $240
Benzinga - 2026-07-30
HC Wainwright & Co. Maintains Buy on Biogen, Raises Price Target to $251
Benzinga - 2026-07-30
Morgan Stanley Maintains Equal-Weight on Biogen, Raises Price Target to $231
Benzinga - 2026-07-30
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $240
Benzinga - 2026-07-30
Canaccord Genuity Maintains Buy on Biogen, Raises Price Target to $248
Benzinga - 2026-07-30
TD Cowen Maintains Buy on Biogen, Raises Price Target to $225
Benzinga - 2026-07-30
Wedbush Maintains Neutral on Biogen, Raises Price Target to $215
Yahoo - 2026-07-30
Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth – Is Profitability Peaking?
Yahoo - 2026-07-29
Why Biogen Stock Topped the Market Today
Yahoo - 2026-07-29
Biogen Inc (BIIB) Q2 2026 Earnings Call Highlights: Strong Growth in Core Pharmaceuticals and ...
Yahoo - 2026-07-29
Biogen Inc. Q2 2026 Earnings Call Summary
Yahoo - 2026-07-29
Drugmakers Climb On Q2 Reports, Even As One Misses Profit Views
Yahoo - 2026-07-29
Why Biogen Stock Is Resisting a Market Downturn After Earnings
SeekingAlpha - 2026-07-29
Biogen Inc. (BIIB) Q2 2026 Earnings Call Transcript
Yahoo - 2026-07-29
Biogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised
Yahoo - 2026-07-29
Biogen Q2 Earnings Call Highlights
Yahoo - 2026-07-29
Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Benzinga - 2026-07-29
Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio
Yahoo - 2026-07-29
Biogen Beats Second-Quarter Expectations as Growth Portfolio Drives Revenue Higher
Yahoo - 2026-07-29
Biogen (NASDAQ:BIIB) Reports Upbeat Q2 CY2026
Yahoo - 2026-07-29
Why This Drugmaker’s Earnings Guidance Cut Doesn’t Tell the Full Story
Yahoo - 2026-07-29
Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
SeekingAlpha - 2026-07-29
Biogen: The Turnaround Is Real Enough To Buy (Rating Upgrade)
Yahoo - 2026-07-29
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Yahoo - 2026-07-29
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
Yahoo - 2026-07-29
Biogen Raises Revenue Guidance as Growth Portfolio Outpaces Legacy Blockbuster Drugs
Benzinga - 2026-07-29
CORRECTION: Biogen Raises FY2026 Adj EPS Guidance from $15.25-$16.25 to $15.85-$16.85 vs $12.83 Est
SeekingAlpha - 2026-07-29
Biogen Inc. 2026 Q2 - Results - Earnings Call Presentation
Benzinga - 2026-07-29
Barclays Maintains Equal-Weight on Biogen, Raises Price Target to $200
Yahoo - 2026-07-28
Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings
Yahoo - 2026-07-28
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
Yahoo - 2026-07-27
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
SeekingAlpha - 2026-07-27
A Deeper Dive Into Design Therapeutics
Yahoo - 2026-07-24
Biogen Q2 Earnings: Can New Drugs Counter Falling MS Sales?
Yahoo - 2026-07-23
Will PTC Therapeutics (PTCT) Report Negative Earnings Next Week? What You Should Know
Yahoo - 2026-07-22
Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for
SeekingAlpha - 2026-07-21
Biogen And The Limitation Of The Tau Approach To Alzheimer's Disease
Yahoo - 2026-07-21
3 Profitable Stocks We Steer Clear Of
Benzinga - 2026-07-21
Guggenheim Maintains Buy on Biogen, Raises Price Target to $280
Benzinga - 2026-07-21
B of A Securities Maintains Neutral on Biogen, Lowers Price Target to $215
Yahoo - 2026-07-20
VERAXA Biotech Shows Regulatory Progress on Cancer Therapy Platform
SeekingAlpha - 2026-07-18
Stoke Therapeutics: Its Dravet Syndrome Lead Asset Enters The Last Stretch
Yahoo - 2026-07-16
Slate Medicines Appoints Mark W. Hahn to Board of Directors
Yahoo - 2026-07-16
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide
Yahoo - 2026-07-15
3 Reasons to Avoid BIIB and 1 Stock to Buy Instead
Yahoo - 2026-07-15
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
Yahoo - 2026-07-15
Biogen Appoints Michael J. Parini as Chief Legal Officer
Yahoo - 2026-07-15
AAIC26: Biogen stock drops after unveiling tau-targeting ASO data
SeekingAlpha - 2026-07-15
Tau In The Clinic, Again
ChartMill - 2026-07-14
Discover which S&P500 stocks are making waves on Tuesday.
Yahoo - 2026-07-14
IBM, Goldman Sachs, SK Hynix, Micron, AMD, Apple, and More Stocks That Explain Today’s Market
Yahoo - 2026-07-14
Biogen Backs Alzheimer’s Tau Drug for Phase 3 Despite Trial Miss
SeekingAlpha - 2026-07-14
Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 - Slideshow
Yahoo - 2026-07-14
BIIB Stock On Track For Worst Day In 2 Years After RBC Questions If Alzheimer’s Drug Benefits Will Replicate In Further Study
Yahoo - 2026-07-14
Biogen stock falls 8% on Alzheimer's drug diranersen trial data
SeekingAlpha - 2026-07-14
Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 Transcript
ChartMill - 2026-07-14
These S&P500 stocks have an unusual volume in today's session
ChartMill - 2026-07-14
These S&P500 stocks are moving in today's session
Yahoo - 2026-07-14
Biogen Wins FDA Approval for Subcutaneous Starter Dose of Leqembi
Yahoo - 2026-07-14
Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'
ChartMill - 2026-07-14
What's going on in today's session: S&P500 gap up and gap down stocks
Yahoo - 2026-07-14
Ionis Begins Dosing in Phase I/II Dravet Syndrome Study
Yahoo - 2026-07-14
Can Biogen Score Another Win In Alzheimer's Disease?
Yahoo - 2026-07-14
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
Benzinga - 2026-07-14
Why Is Biogen Stock Falling Tuesday?
Yahoo - 2026-07-14
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
Yahoo - 2026-07-13
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
Yahoo - 2026-07-13
BIIB Stock Jumps 5% — Analysts Raise Price Targets After FDA Clears Alzheimer’s Treatment For At-Home Use
Yahoo - 2026-07-13
Stock Market Today, July 13: SK Hynix Tumbles 15% in South Korea, Leading Semiconductor Drop at Midday
Yahoo - 2026-07-13
Stock Market Today, July 13: Energy Stocks Cushion Dow as Tech Slides on Geopolitical Tensions
Benzinga - 2026-07-13
FDA Grants Approval For At-Home Starting Dose For Alzheimer's Treatment Leqembi
Yahoo - 2026-07-13
American Express, Biogen upgraded: Wall Street's top analyst calls
CNBC - 2026-07-13
Stocks making the biggest moves midday: Nio, Braiin, AppLovin, SpaceX, SK Hynix & more
Benzinga - 2026-07-13
This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Benzinga - 2026-07-13
Truist Securities Upgrades Biogen to Buy, Raises Price Target to $235
Yahoo - 2026-07-10
Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up
Yahoo - 2026-07-10
The Long Climb Back For Ionis Stock
Yahoo - 2026-07-10
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Yahoo - 2026-07-09
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
Yahoo - 2026-07-09
Biogen's Q2 2026 Earnings: What to Expect
Yahoo - 2026-07-09
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?
Yahoo - 2026-07-08
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
Benzinga - 2026-07-08
Morgan Stanley Maintains Equal-Weight on Biogen, Lowers Price Target to $222
Benzinga - 2026-07-08
Congressional Trading Report: Rep. Maria Elvira Salazar Bought Over $50K In Brookfield Renewable Stock
Yahoo - 2026-07-08
Moderna Appoints Michael McDonnell to Board of Directors
Yahoo - 2026-07-07
IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study
Yahoo - 2026-07-07
Why Biogen (BIIB) is Poised to Beat Earnings Estimates Again
Benzinga - 2026-07-07
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $242
Yahoo - 2026-07-07
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
Yahoo - 2026-07-06
3 Healthcare ETFs to Own in a Choppy Stock Market
Yahoo - 2026-07-05
Here is Why Biogen (BIIB) is One of the Most Undervalued NASDAQ Stocks to Buy Right Now
Yahoo - 2026-07-04
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
Yahoo - 2026-07-02
BIIB Stock Ends 3% Higher — Why This Strategist Picks Biogen Over Other Biotech Peers
Yahoo - 2026-07-02
1 S&P 500 Stock with Promising Prospects and 2 We Question
Yahoo - 2026-07-02
Is Biogen (BIIB) Priced Near Fair Value After Its 57% Run?
Yahoo - 2026-07-01
Biogen (BIIB) To Share New Alzheimer’s Data At AAIC 2026
Benzinga - 2026-07-01
Biogen Expects $164M Q2 2026 And $290M-$320M Q3 2026 IPR&D And Milestone Charges, Impacting Earnings By $0.95 And $1.75–$1.95 Per Share, Respectively
Yahoo - 2026-07-01
Amgen or Biogen: Which Biotech Stock Appears Better Poised?
Yahoo - 2026-07-01
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
Yahoo - 2026-06-30
New Strong Sell Stocks for June 30th
Yahoo - 2026-06-29
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
Yahoo - 2026-06-29
Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?
Yahoo - 2026-06-29
Biogen trims Apellis pipeline and R&D team after $5.6bn takeover
Benzinga - 2026-06-29
Biogen: Key Takeaways From Needham’s Meeting With Top Management
Yahoo - 2026-06-29
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
Benzinga - 2026-06-29
Needham Maintains Buy on Biogen, Raises Price Target to $256
Yahoo - 2026-06-26
Why Biogen (BIIB) Stock Is Up Today
Yahoo - 2026-06-26
Lilly, J&J and AbbVie Hit New Highs
CNBC - 2026-06-26
Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more
Yahoo - 2026-06-26
Can Biogen's New Drugs Revive Growth Amid Legacy Sales Slump?
Yahoo - 2026-06-25
Axtria Ignite 2026: 450+ Life Sciences Leaders Convene With a Contrarian Message -- Fix the Foundation Before You Scale AI
Yahoo - 2026-06-23
Therapeutics Stocks Q1 Recap: Benchmarking Biogen (NASDAQ:BIIB)
Yahoo - 2026-06-19